Bactericidal activity of silver nanoparticles in drug-resistant bacteria

Braz J Microbiol. 2023 Jun;54(2):691-701. doi: 10.1007/s42770-023-00991-7. Epub 2023 May 2.

Abstract

Bacterial resistance to multiple drugs is a worldwide problem that afflicts public health. Various studies have shown that silver nanoparticles are good bactericidal agents against bacteria due to the adherence and penetration of the external bacterial membrane, preventing different vital functions and subsequently bacterial cell death. A systematic review of ScienceDirect, PubMed, and EBSCOhost was conducted to synthesize the literature evidence on the association between the bactericidal property of silver nanoparticles on both resistant Gram-positive and Gram-negative bacteria. Eligible studies were original, comparative observational studies that reported results on drug-resistant bacteria. Two independent reviewers extracted the relevant information. Out of the initial 1 420, 142 studies met the inclusion criteria and were included to form the basis of the analysis. Full-text screening led to the selection of 6 articles for review. The results of this systematic review showed that silver nanoparticles act primarily as bacteriostatic agents and subsequently as bactericides, both in Gram-positive and Gram-negative drug-resistant bacteria.

Keywords: Drug-resistant bacteria; Gram-negative bacteria; Gram-positive bacteria.

Publication types

  • Systematic Review
  • Review

MeSH terms

  • Anti-Bacterial Agents* / pharmacology
  • Bacteria
  • Gram-Negative Bacteria
  • Gram-Positive Bacteria
  • Metal Nanoparticles*
  • Microbial Sensitivity Tests
  • Silver / pharmacology

Substances

  • Anti-Bacterial Agents
  • Silver